Showing 141 - 150 of 750
This paper provides an account of the Emerging Markets Corporate Governance Research Network (EMCGN) and its first 10 years of activities. The network was established under the auspices of the Global Corporate Governance Forum (now incorporated into IFC's Corporate Governance Group). The paper...
Persistent link: https://www.econbiz.de/10012248319
Persistent link: https://www.econbiz.de/10011253622
Persistent link: https://www.econbiz.de/10006092050
Persistent link: https://www.econbiz.de/10010146190
An important issue in evaluating corporate governance is how to measure it. In prior work on emerging markets, we have advocated measuring firm-level governance using country-specific indices, tailored to each country's laws and institutions. An alternate approach, used in commercial indices, is...
Persistent link: https://www.econbiz.de/10012913459
Three problems pose severe challenges to identify the impact of corporate social responsibility (CSR) on firm value and performance. These are construct validity, limited data, and endogeneity. To deal with them we use a broad composite measure of CSR and panel data with firm fixed and random...
Persistent link: https://www.econbiz.de/10012981886
The Third International Conference on Corporate Governance in Emerging Markets is one in a series of academic events organized by the Emerging Markets Corporate Governance Network (EMCGN). The Global Corporate Governance Forum at IFC endorses and supports the Network, which was first convened by...
Persistent link: https://www.econbiz.de/10014170310
A central issue in evaluating the effects of firm-level corporate governance (FLCG) is how to measure it. We focus here on emerging markets (EMs). One common approach to measuring FLCG uses country-specific (CSIs), tailored to each country’s laws and institutions. Several studies report that...
Persistent link: https://www.econbiz.de/10014254555
This paper reviews recent research on corporate governance, with a special focus on emerging markets. It finds that better corporate frameworks benefit firms through greater access to financing, lower cost of capital, better performance, and more favorable treatment of all stakeholders. Numerous...
Persistent link: https://www.econbiz.de/10013112084
Pharmaceutical firms frequently attract political attention due to their high accounting profitability. We study the U.S. pharmaceutical industry to test the two opposing views of how regulators use accounting information in the political process: The “public interest hypothesis” predicts...
Persistent link: https://www.econbiz.de/10014140245